SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : biotech fireworks
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jibacoa who wrote (361)11/4/2002 10:34:30 AM
From: Jibacoa  Read Replies (1) of 7424
 
SUPG has been up only 14.24% (so far <g>),short of the 15% required for inclusion on today's list, but this will be the 4th day of its recent up-move.

I don't have an idea of what the chances are for approval of rubetican for oral treatment of pancreatic Ca.(Have to look at the reported results.)

Also have to look at results of their decitabine Phase II on patients with MDS, on the October issue of Blood.

bigcharts.marketwatch.com

Bernard
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News